POM
Pomdoctor Limited
Price Chart
Latest Quote
$1.29
+1.21 (+1385.88%)
Current Price
| Previous Close | $0.09 |
| Open | $0.09 |
| Day High | $0.09 |
| Day Low | $0.07 |
| Volume | 2,829,848 |
Stock Information
Note: Financial values converted from CNY to USD
| Shares Outstanding | 121.94M |
| Total Debt | $67.26M |
| Cash Equivalents | $1.42M |
| Revenue | $59.13M |
| Net Income | $-31.43M |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Market Cap | $173.67M |
| EPS (TTM) | $-5.03 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $591.71M |
| Sales | $59.13M |
| Income | $-31.43M |
| Book/sh | $-0.48 |
| Cash/sh | $0.08 |
| Employees | 165 |
Financial Ratios
| Quick Ratio | 0.14 |
| Current Ratio | 0.48 |
Returns & Margins
| ROA | -94.72% |
| Gross Margin | 13.07% |
| Operating Margin | -46.62% |
| Profit Margin | -53.16% |
Ownership
| Institutional Ownership | 0.69% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.43 |
| P/B | -2.68 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.89 |
| SMA50 | $4.08 |
| RSI | 29.84 |
| ATR | 0.2764 |
| Shares Float | 52.68M |
| Short Float | 0.04% |
| Short Ratio | 0.03 |
| Rel Volume | 2.05 |
Performance History
| Week | -33.73% |
| Month | -40.73% |
| Quarter | -80.08% |
| 6 Months | -77.88% |
| YTD | -77.94% |
| 10 Years | -98.22% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.29 | 157,213 |
| 2026-06-17 | $1.57 | 50,881 |
| 2026-06-16 | $1.63 | 47,524 |
| 2026-06-15 | $1.76 | 34,591 |
| 2026-06-12 | $1.83 | 37,415 |
| 2026-06-11 | $1.95 | 54,129 |
| 2026-06-10 | $2.11 | 136,111 |
| 2026-06-09 | $1.95 | 188,525 |
| 2026-06-08 | $2.02 | 229,183 |
| 2026-06-05 | $1.78 | 60,331 |
| 2026-06-04 | $1.81 | 16,312 |
| 2026-06-03 | $1.83 | 33,458 |
| 2026-06-02 | $1.90 | 60,815 |
| 2026-06-01 | $1.88 | 29,429 |
| 2026-05-29 | $1.88 | 48,672 |
| 2026-05-28 | $1.91 | 102,243 |
| 2026-05-27 | $2.08 | 74,789 |
| 2026-05-26 | $1.96 | 39,754 |
| 2026-05-22 | $2.21 | 41,976 |
| 2026-05-21 | $2.39 | 92,928 |
| 2026-05-20 | $2.24 | 49,697 |
| 2026-05-19 | $2.18 | 41,315 |
About Pomdoctor Limited
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $51,389,247 | $43,588,608 | $39,341,167 | $28,139,520 |
| Cost Of Revenue | $51,389,247 | $43,588,608 | $39,341,167 | $28,139,520 |
| Total Revenue | $59,117,913 | $50,639,039 | $45,065,259 | $36,249,458 |
| Operating Revenue | $59,117,913 | $50,639,039 | $45,065,259 | $36,249,458 |
| Expenses | ||||
| Interest Expense | $1,904,759 | $1,916,505 | $2,047,263 | $2,368,673 |
| Total Expenses | $76,320,997 | $54,092,740 | $48,069,133 | $36,739,372 |
| Other Income Expense | $-247,272 | $-153,384 | $-410,957 | $-73,106 |
| Other Non Operating Income Expenses | $64,422 | $177,529 | $-173,396 | $-73,106 |
| Net Non Operating Interest Income Expense | $-1,904,759 | $-1,916,505 | $-2,047,263 | $-2,368,673 |
| Interest Expense Non Operating | $1,904,759 | $1,916,505 | $2,047,263 | $2,368,673 |
| Operating Expense | $24,931,750 | $10,504,133 | $8,727,966 | $8,599,851 |
| Other Operating Expenses | $-22,558 | $-28,013 | $-47,537 | $-41,415 |
| Selling And Marketing Expense | $14,223,011 | $8,332,436 | $6,456,854 | $7,015,649 |
| General And Administrative Expense | $8,829,564 | $1,755,929 | $1,820,335 | $1,095,232 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,354,945 | $-5,527,416 | $-5,462,249 | $-2,931,416 |
| Net Interest Income | $-1,904,759 | $-1,916,505 | $-2,047,263 | $-2,368,673 |
| Normalized Income | $-19,121,174 | $-5,196,503 | $-5,224,688 | $-2,931,416 |
| Net Income From Continuing And Discontinued Operation | $-19,354,945 | $-5,527,416 | $-5,462,249 | $-2,931,416 |
| Total Operating Income As Reported | $-17,537,336 | $-3,812,627 | $-3,288,971 | $-531,329 |
| Net Income Common Stockholders | $-31,424,765 | $-21,192,502 | $-21,492,576 | $-18,553,701 |
| Net Income | $-31,424,765 | $-21,192,502 | $-21,492,576 | $-18,553,701 |
| Net Income Including Noncontrolling Interests | $-31,424,990 | $-21,188,677 | $-21,492,419 | $-18,553,979 |
| Net Income From Tax Loss Carryforward | $-12,069,820 | $-15,665,086 | $-16,030,327 | $-15,622,286 |
| Net Income Continuous Operations | $-19,355,170 | $-5,523,590 | $-5,462,093 | $-2,931,694 |
| Pretax Income | $-19,355,114 | $-5,523,590 | $-5,462,093 | $-2,931,694 |
| Special Income Charges | $-311,694 | $-330,913 | $-237,561 | $0 |
| Operating Income | $-17,203,084 | $-3,453,701 | $-3,003,873 | $-489,914 |
| Gross Profit | $7,728,666 | $7,050,431 | $5,724,092 | $8,109,937 |
| Per Share | ||||
| Diluted EPS | $-0.54 | $-0.18 | $-0.18 | $-0.16 |
| Basic EPS | $-0.54 | $-0.18 | $-0.18 | $-0.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $-77,924 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-17,116,590 | $-3,256,288 | $-3,160,699 | $-563,020 |
| Total Unusual Items | $-311,694 | $-330,913 | $-237,561 | $0 |
| Total Unusual Items Excluding Goodwill | $-311,694 | $-330,913 | $-237,561 | $0 |
| Reconciled Depreciation | $22,071 | $19,884 | $16,570 | $0 |
| EBITDA (Bullshit earnings) | $-17,428,284 | $-3,587,201 | $-3,398,260 | $-563,020 |
| EBIT | $-17,450,355 | $-3,607,085 | $-3,414,830 | $-563,020 |
| Diluted Average Shares | $8,586,298 | $17,509,210 | $17,509,210 | $17,509,210 |
| Basic Average Shares | $8,586,298 | $17,509,210 | $17,509,210 | $17,509,210 |
| Diluted NI Availto Com Stockholders | $-31,424,765 | $-21,192,502 | $-21,492,576 | $-18,553,701 |
| Minority Interests | $225 | $-3,825 | $-156 | $278 |
| Tax Provision | $55 | $0 | $0 | $0 |
| Write Off | $0 | $0 | $73,913 | $0 |
| Impairment Of Capital Assets | $311,694 | $330,913 | $163,648 | $0 |
| Research And Development | $1,901,733 | $443,780 | $498,314 | $530,385 |
| Selling General And Administration | $23,052,575 | $10,088,365 | $8,277,188 | $8,110,881 |
| Other Gand A | $8,829,564 | $1,755,929 | $1,820,335 | $1,095,232 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-67,108,852 | $-334,593,084 | $-313,399,808 | $-291,907,233 |
| Total Assets | $15,899,807 | $6,833,649 | $9,801,986 | $7,186,969 |
| Total Non Current Assets | $382,988 | $1,290,548 | $1,018,521 | $129,736 |
| Other Non Current Assets | $198,713 | $122,863 | $81,231 | $55,823 |
| Non Current Deferred Assets | $0 | $1,099,484 | $849,205 | $0 |
| Current Assets | $15,516,818 | $5,543,100 | $8,783,465 | $7,057,233 |
| Prepaid Assets | $9,207,356 | $843,496 | $1,113,096 | $1,425,900 |
| Inventory | $1,224,022 | $1,354,971 | $1,876,568 | $1,211,514 |
| Receivables | $3,669,211 | $2,213,512 | $4,787,829 | $4,028,745 |
| Receivables Adjustments Allowances | $-335,655 | $-395,853 | $-292,547 | $-213,870 |
| Other Receivables | $91,948 | $79,551 | $68,563 | $63,059 |
| Taxes Receivable | $526,374 | $396,408 | $422,206 | $0 |
| Accounts Receivable | $2,848,895 | $1,300,703 | $4,234,281 | $4,179,555 |
| Allowance For Doubtful Accounts Receivable | $-97,913 | $-119,199 | $-125,162 | $0 |
| Gross Accounts Receivable | $2,946,807 | $1,419,903 | $4,359,443 | $4,179,555 |
| Cash Cash Equivalents And Short Term Investments | $1,416,229 | $1,131,121 | $992,953 | $367,437 |
| Cash And Cash Equivalents | $1,416,229 | $1,131,121 | $992,953 | $367,437 |
| Restricted Cash | - | $0 | $13,019 | $23,637 |
| Debt | ||||
| Net Debt | $65,416,057 | $63,623,080 | $59,735,622 | $51,131,342 |
| Total Debt | $67,252,041 | $65,206,709 | $61,095,727 | $53,400,944 |
| Long Term Debt And Capital Lease Obligation | $54,797,099 | $54,217,196 | $52,717,791 | $48,837,422 |
| Long Term Debt | $54,605,737 | $53,969,998 | $52,538,001 | $47,145,900 |
| Current Debt And Capital Lease Obligation | $12,454,942 | $10,989,514 | $8,377,936 | $4,563,523 |
| Current Debt | $12,226,550 | $10,784,203 | $8,190,574 | $4,352,879 |
| Other Current Borrowings | $4,391,761 | $5,616,445 | $4,938,398 | $2,868,399 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $87,048,068 | $316,490,018 | $299,751,217 | $287,761,480 |
| Total Non Current Liabilities Net Minority Interest | $54,797,099 | $290,007,622 | $274,325,443 | $266,532,447 |
| Current Liabilities | $32,250,969 | $26,482,396 | $25,425,774 | $21,229,033 |
| Current Deferred Liabilities | $235,211 | $259,590 | $183,811 | $403,957 |
| Payables And Accrued Expenses | $19,560,816 | $14,925,732 | $16,864,027 | $16,261,554 |
| Interest Payable | $6,626,563 | $5,432,461 | $5,623,660 | $4,254,441 |
| Payables | $10,778,850 | $8,057,439 | $9,792,356 | $10,544,845 |
| Other Payable | $3,887,143 | $4,178,202 | $3,405,913 | $3,839,653 |
| Total Tax Payable | $97,415 | $120,547 | $31,606 | $48,661 |
| Accounts Payable | $6,625,748 | $3,746,859 | $6,162,741 | $6,407,856 |
| Other Current Liabilities | - | $307,561 | - | - |
| Equity | ||||
| Common Stock Equity | $-67,108,852 | $-334,593,084 | $-313,399,808 | $-291,907,233 |
| Total Equity Gross Minority Interest | $-71,148,261 | $-309,656,369 | $-289,949,231 | $-280,574,511 |
| Stockholders Equity | $-67,108,852 | $-334,593,084 | $-313,399,808 | $-291,907,233 |
| Other Equity Interest | $-323 | $-238 | $-238 | - |
| Gains Losses Not Affecting Retained Earnings | $-259,060 | $-773 | $0 | - |
| Other Equity Adjustments | $-259,060 | $-773 | - | - |
| Retained Earnings | $-366,017,488 | $-334,592,723 | $-313,400,221 | $-291,907,645 |
| Preferred Securities Outside Stock Equity | $0 | $235,790,427 | $221,607,652 | $217,695,025 |
| Other | ||||
| Ordinary Shares Number | $3,427,050 | $2,918,202 | $2,918,202 | $2,918,202 |
| Share Issued | $3,427,050 | $2,918,202 | $2,918,202 | $2,918,202 |
| Tangible Book Value | $-67,108,852 | $-334,593,084 | $-313,399,808 | $-291,907,233 |
| Invested Capital | $-276,565 | $-269,838,883 | $-252,671,234 | $-240,408,454 |
| Working Capital | $-16,734,150 | $-20,939,296 | $-16,642,309 | $-14,171,800 |
| Capital Lease Obligations | $419,754 | $452,508 | $367,152 | $1,902,165 |
| Total Capitalization | $-12,503,115 | $-280,623,086 | $-260,861,808 | $-244,761,333 |
| Minority Interest | $-4,039,410 | $24,936,715 | $23,450,577 | $11,332,722 |
| Additional Paid In Capital | $299,165,594 | $0 | - | - |
| Capital Stock | $2,425 | $650 | $650 | $412 |
| Common Stock | $2,425 | $650 | $650 | $412 |
| Long Term Capital Lease Obligation | $191,363 | $247,198 | $179,790 | $1,691,522 |
| Current Deferred Revenue | $235,211 | $259,590 | $183,811 | $403,957 |
| Current Capital Lease Obligation | $228,392 | $205,310 | $187,362 | $210,643 |
| Line Of Credit | $7,834,789 | $5,167,758 | $3,252,177 | $1,484,480 |
| Current Accrued Expenses | $8,781,967 | $6,868,292 | $7,071,671 | $5,716,709 |
| Dueto Related Parties Current | $168,544 | $11,832 | $192,095 | $248,675 |
| Net PPE | $184,275 | $68,201 | $88,085 | $0 |
| Accumulated Depreciation | $-1,608,924 | $-1,599,278 | $-1,580,341 | $-1,583,625 |
| Gross PPE | $1,793,199 | $1,667,479 | $1,668,426 | $1,583,625 |
| Leases | $703,495 | $703,495 | $703,495 | $717,613 |
| Machinery Furniture Equipment | $1,089,704 | $963,983 | $964,931 | $866,013 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-278,451 | $-73,094 | $-74,368 | - |
| Finished Goods | $1,502,473 | $1,428,065 | $1,950,936 | $1,211,514 |
| Duefrom Related Parties Current | $537,650 | $832,703 | $355,327 | - |
| Investments And Advances | - | - | $0 | $73,913 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-22,098,157 | $-2,390,151 | $-6,786,343 | $-3,254,734 |
| Operating Activities | ||||
| Operating Cash Flow | $-21,949,184 | $-2,384,567 | $-6,769,802 | $-3,254,734 |
| Cash Flow From Continuing Operating Activities | $-21,949,184 | $-2,384,567 | $-6,769,802 | $-3,254,734 |
| Operating Gains Losses | - | $-575 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-148,972 | $-5,584 | $-16,540 | - |
| Investing Cash Flow | $-237,668 | $-4,933 | $-16,540 | $0 |
| Cash Flow From Continuing Investing Activities | $-237,668 | $-4,933 | $-16,540 | $0 |
| Net Other Investing Changes | $-88,696 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $24,233,537 | $0 | $0 | - |
| Financing Cash Flow | $22,754,402 | $2,515,423 | $7,401,241 | $3,324,902 |
| Cash Flow From Continuing Financing Activities | $22,754,402 | $2,515,423 | $7,401,241 | $3,324,902 |
| Net Other Financing Charges | $-3,557,220 | - | $-336,589 | - |
| Net Common Stock Issuance | $24,233,537 | $0 | $0 | - |
| Common Stock Issuance | $24,233,537 | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-11,334,167 | $-10,087,942 | $-12,448,454 | $-1,912,217 |
| Issuance Of Debt | $13,412,253 | $12,603,364 | $20,186,284 | $5,237,120 |
| Interest Paid Supplemental Data | $399,663 | $405,752 | $353,013 | $478,340 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $1,416,229 | $1,131,121 | $1,005,972 | $391,073 |
| Beginning Cash Position | $1,131,121 | $1,005,972 | $391,073 | $320,906 |
| Effect Of Exchange Rate Changes | $-282,442 | $-773 | $0 | - |
| Changes In Cash | $567,550 | $125,922 | $614,899 | $70,168 |
| Net Issuance Payments Of Debt | $2,078,085 | $2,515,423 | $7,737,831 | $3,324,902 |
| Net Short Term Debt Issuance | $2,667,031 | $1,915,581 | $1,823,511 | $1,267,401 |
| Short Term Debt Payments | $-5,611,237 | $-4,603,555 | $-2,315,623 | $-225,378 |
| Short Term Debt Issuance | $8,278,268 | $6,519,136 | $4,139,134 | $1,492,779 |
| Net Long Term Debt Issuance | $-588,946 | $599,841 | $5,914,319 | $2,057,502 |
| Long Term Debt Payments | $-5,722,931 | $-5,484,387 | $-10,132,831 | $-1,686,839 |
| Long Term Debt Issuance | $5,133,985 | $6,084,228 | $16,047,150 | $3,744,341 |
| Net PPE Purchase And Sale | $-148,972 | $-4,933 | $-16,540 | $0 |
| Sale Of PPE | $0 | $650 | $0 | $0 |
| Purchase Of PPE | $-148,972 | $-5,584 | $-16,540 | $0 |
| Change In Working Capital | $-5,598,458 | $2,591,286 | $-1,856,242 | $-208,557 |
| Change In Other Working Capital | $-24,379 | $75,778 | $-220,146 | $188,693 |
| Change In Other Current Liabilities | $-641,182 | $148,492 | $-294,811 | $-370,673 |
| Change In Other Current Assets | $12,846 | $-41,633 | $-25,407 | $0 |
| Change In Payables And Accrued Expense | $4,985,693 | $-759,350 | $89,858 | $4,121,031 |
| Change In Accrued Expense | $719,572 | $-12,180 | $-14,258 | $68,249 |
| Change In Payable | $4,266,121 | $-747,170 | $104,115 | $4,052,782 |
| Change In Account Payable | $2,878,889 | $-2,415,883 | $-245,114 | $1,913,094 |
| Change In Tax Payable | $-23,132 | $88,866 | $-17,055 | $-4,770 |
| Change In Income Tax Payable | $-23,132 | $88,866 | $-17,055 | $-4,770 |
| Change In Prepaid Assets | $36,952 | $288,381 | $-7,938 | $-182,154 |
| Change In Inventory | $-147,502 | $448,503 | $-739,422 | $-11,466 |
| Change In Receivables | $-9,820,887 | $2,431,114 | $-658,376 | $-3,953,988 |
| Changes In Account Receivables | $-1,553,146 | $2,939,540 | $-188,261 | $-3,857,859 |
| Stock Based Compensation | $2,427,851 | $0 | $0 | - |
| Provisionand Write Offof Assets | $242,827 | $197,517 | $294,402 | $-114,484 |
| Asset Impairment Charge | $311,694 | $330,913 | $237,561 | $0 |
| Depreciation Amortization Depletion | $22,071 | $19,884 | $16,570 | $0 |
| Depreciation And Amortization | $22,071 | $19,884 | $16,570 | $0 |
| Depreciation | $22,071 | $19,884 | $16,570 | $0 |
| Gain Loss On Sale Of PPE | $0 | $-575 | $0 | - |
| Net Income From Continuing Operations | $-19,355,170 | $-5,523,590 | $-5,462,093 | $-2,931,694 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Amortization Cash Flow | - | - | - | $0 |
| Amortization Of Intangibles | - | - | - | $0 |
Fetched: 2026-06-21